• RESEARCH

    Patient-derived organ-on-a-chip platform predicts chemotherapy response in locally advanced CRC

    From a cohort of 14 primary locally advanced CRC cases, researchers engineered 8 patient-specific organ-on-a-chip models that successfully stratified patients into distinct response groups for FOLFOX versus FOLFIRI. (Bioeng Transl Med)